If you ever get discouraged feeling that nothing impactful is being done to improve Type 1 diabetes at the point of care (getting doctors on board, etc.), have a look at the Helmsley Charitable Trust. I too was pretty unfamiliar with their efforts until recent conversations on my conference tour through Orlando.
Since April of 2009, Helmsley has begun a multi-million dollar Type 1 Diabetes program that consists of four parts: a research consortium, a…
Read more »
There were a number of encouraging news announcements this week here in Florida about progress on the JDRF’s Artificial Pancreas Project. The most prominent of those is today’s unveiling of the results of the STAR 3 Trial (Sensor-Augmented Pump Therapy for A1C Reduction) that showed adults, teens and children achieving a 4x reduction in A1C levels using this tech-heavy therapy versus patients on injections.
The STAR study, sponsored by Medtronic, was conducted at 30 clinics…
Read more »
Get ready for a slew of diabetes news announcements, because the ADA’s huge annual conference starts today!
I’ll be on an airplane pretty much all day (Friday) heading out to Orlando to cover this conference live, although I must warn you: it’s quite overwhelming. Running around the 450,000 square-foot convention center trying to see every diabetes company represented in the enormous exhibit halls while hundreds of symposia and other talk sessions are happening simultaneously is…
Read more »
By
AmyT on
April 22, 2010
Technology blogger and Type 1 diabetic Scott Hanselman works for Microsoft, and is quite famous in software developer circles. As it happens, he’s been wearing the brand new “Revel” combo Insulin Pump and Continuous Glucose Monitor (CGM) system from Medtronic for six days now, and has just posted his thoughts on his tech blog, Computer Zen. He’s also kindly agreed to allow me to publish simultaneously here at the ‘Mine.
A Review of the Paradigm…
Read more »
By
AmyT on
March 22, 2010
Many of you may know that the FDA held a two-day Public Hearing on the issue of Glucose Meter Accuracy late last week. Dozens of experts gathered at the Washington DC Hilton/Gaithersburg Hotel to lend testimony.
The issue at hand, according to FDA statements, is that:
“Glucose meters are increasingly being used to achieve tight glycemic control despite the fact that these devices have not been approved for this use. There is currently no consensus…
Read more »
